← Open Payments lookup

MARTI WILLEY: Open Payments

NPI 1144574062 · ENCINITAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,680 in 215 payments from 50 companies in 2025. Trend: 2023 $8,060 · 2024 $12,963 · 2025 $6,680

Food & beverage: $6,334Education: $337Long term medical supply or device loan: $83
CompanyPaymentsAmount
Janssen Biotech, Inc.13$768
AstraZeneca Pharmaceuticals LP17$578
ABBVIE INC.20$508
Gilead Sciences, Inc.16$434
PFIZER INC.15$413
Eisai Inc.9$392
Merck Sharp & Dohme LLC12$303
GENZYME CORPORATION9$279
Novartis Pharmaceuticals Corporation5$196
Incyte Corporation5$195

Products named: RYBREVANT, EPKINLY, Lenvima, KEYTRUDA, SARCLISA, Trodelvy, TECVAYLI, ELREXFIO.

Industry payments across CA — which companies pay providers there.